Clorox (CLX) Tops Q1 EPS by 14c

Clorox (NYSE: CLX) reported Q1 EPS of $1.32, $0.14 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.39 billion versus the consensus estimate of $1.38 billion.

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c